Medical Devices
-
Medtronic elevates Sean Haag to president of ENT
Haag, who has worked at Medtronic for 20 years, will also serve on the leadership team for the neuroscience group.
By Susan Kelly • March 11, 2026 -
Coloplast names former J&J executive Gavin Wood as CEO
Wood spent 20 years at J&J, culminating in a spell as company group chairman for the medtech business in Europe, the Middle East and Africa.
By Nick Paul Taylor • March 11, 2026 -
Explore the Trendline➔
Courtesy of Intuitive Surgical
TrendlineTop 5 stories from MedTech Dive
From the top medtech trends to watch in 2026 to haphazard layoffs at the Food and Drug Administration and the evolving use of AI in the medtech sector, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Vitestro raises $70M to ready blood collection robot for US launch
The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.
By Nick Paul Taylor • March 11, 2026 -
ARPA-H launches program to develop biosensors that can track multiple signals
The research initiative is part of a broader focus on wearables at the Department of Health and Human Services.
By Elise Reuter • March 10, 2026 -
Medtronic to acquire Scientia Vascular for $550M
The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.
By Susan Kelly • March 10, 2026 -
SS Innovations raises $18.6M as surgical robot nears US market
Intuitive co-founder Fred Moll invested $2 million, supporting SS Innovations’ efforts to launch its robot in the U.S.
By Nick Paul Taylor • March 10, 2026 -
Science Corporation raises $230M for Prima vision restoration device
The startup is seeking regulatory approval in Europe and the U.S. for the device, which restored vision to patients with late-stage macular degeneration in a small clinical trial.
By Susan Kelly • March 6, 2026 -
Medtronic’s MiniMed goes public for $560M
The diabetes tech business is now operating as a standalone, public company. Shares began trading on Friday.
By Elise Reuter • March 6, 2026 -
Zimmer Biomet shares smart knee data at AAOS
The orthopedic firm published data showing patients with its Persona IQ implant had lower revision and physical therapy rates than those who received traditional knee implants.
By Elise Reuter • March 6, 2026 -
Cognito raises $105M to bring Alzheimer’s treatment device to market
Expecting pivotal data this year, the company has raised a Series C round to support the launch of a noninvasive device designed to treat brain diseases using light and sound.
By Nick Paul Taylor • March 6, 2026 -
Trump tariffs
Tariff refunds: Court provides first step with liquidation order
The Court of International Trade on Wednesday directed Customs and Border Protection to remove defunct tariffs when finalizing non-liquidated entries.
By Phil Neuffer , Antone Gonsalves • March 5, 2026 -
Trump tariffs
US to hike global tariff to 15% ‘sometime this week,’ Bessent says
The Treasury Secretary also said he expects tariff rates struck down by the Supreme Court to return within the next five months, following ongoing trade investigations.
By Phil Neuffer • March 5, 2026 -
Medtech industry calls for FDA staffing transparency in MDUFA talks
Stakeholders also discussed changing international user fees and the FDA’s spending trigger for the program.
By Elise Reuter • March 5, 2026 -
Vicarious Surgical receives NYSE delisting notice
The robotics company, which has taken steps to preserve cash amid the latest change of course in the development of its surgical system, got approval to move its shares to the over-the-counter market.
By Susan Kelly • March 4, 2026 -
Stryker execs discuss Mako RPS launch at AAOS
Keith Evans, general manager of Stryker’s Mako and enabling technologies unit, said the handheld robot will be in a limited release for the first half of 2026.
By Elise Reuter • March 4, 2026 -
Profile
Inside CMR Surgical’s big pivot before US robot launch
CEO Massimiliano Colella delayed introducing the company’s soft tissue surgery system in the U.S. by a year but says the improved robot that is hitting the market now was worth the wait.
By Susan Kelly • March 4, 2026 -
Medtronic, GE HealthCare expand patient monitoring alliance
Expanding the long-running partnership will bring Medtronic technologies, such as the Nellcor pulse oximetry product, to more healthcare settings.
By Nick Paul Taylor • March 4, 2026 -
Retrieved from Fresenius Kabi on March 03, 2026
Fresenius Kabi recalls Ivenix infusion pumps over software problem
Fresenius has issued a software release to address issues that could interrupt treatment with its Ivenix large volume pumps.
By Elise Reuter • March 3, 2026 -
Boston Scientific gets Farapulse label expansion in Europe
With CE mark approval, the pulsed field ablation procedure becomes available to treat patients in Europe with persistent atrial fibrillation.
By Susan Kelly • March 3, 2026 -
FDA warns insulin infusion set maker Unomedical over leaks, mishandled complaints
Unomedical, which supplies diabetes tech firms including Medtronic, Tandem Diabetes Care and Beta Bionics, received more than 5,000 complaints about leaking infusion sets between 2023 and 2025.
By Elise Reuter • March 2, 2026 -
Abbott wins FDA approval for updated heart failure monitoring device
The company redesigned the reader to fit in a carry-on suitcase and be easier to use day to day.
By Nick Paul Taylor • March 2, 2026 -
Trump administration targets DME suppliers in fraud crackdown
The government plans a six-month moratorium on supplier enrollment in the Medicare program to find ways to stop what it called “longstanding instances of fraud, waste, and abuse” by certain companies.
By Susan Kelly • Feb. 27, 2026 -
UFP Technologies investigating cyberattack that impacted company data
The medical device maker warned of short-term shipment delays, but does not see a material impact.
By David Jones • Feb. 27, 2026 -
GE HealthCare forms 10-year imaging alliance with UCSF Health
The partnership covers the implementation of remote scanning and workforce development.
By Nick Paul Taylor • Feb. 27, 2026 -
Medtech M&A starts off strong in 2026
Boston Scientific's planned $14.5 billion acquisition of Penumbra is the largest deal of the year so far.
By Elise Reuter • Feb. 26, 2026